Abundance of the δ subunit of RNA polymerase is linked to the virulence of Streptococcus agalactiae

Journal of Bacteriology

Volumn 188, Issue 6, 2006, Pages 2096-2105

  Seepersaud, Ravin ^a   Needham, Rachel H V ^a,b   Kim, Cathy S ^a   Jones, Amanda L ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b ROSETTA INPHARMATICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID DNA; RECOMBINANT ENZYME; RNA; RNA POLYMERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACILLUS SUBTILIS; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; DNA SEQUENCE; ENZYME PURIFICATION; ENZYME SUBUNIT; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSCRIPTION; NEWBORN; NEWBORN SEPSIS; NONHUMAN; NORTHERN BLOTTING; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RAT; REPORTER GENE; RPOE GENE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; WESTERN BLOTTING;

ANIMALS; ARTIFICIAL GENE FUSION; BACTERIAL PROTEINS; BLOTTING, WESTERN; DNA-DIRECTED RNA POLYMERASES; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; RATS; SEROTYPING; SIGMA FACTOR; STREPTOCOCCUS AGALACTIAE; TRANSCRIPTION FACTORS; VIRULENCE;

ANIMALIA; BACILLUS (BACTERIUM); BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 33644872540     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/JB.188.6.2096-2105.2006     Document Type: Article

References (44)

1. Achberger, E. C., M. D. Hilton, and H. R. Whiteley. 1982. The effect of the delta subunit on the interaction of Bacillus subtilis RNA polymerase with bases in a SP82 early gene promoter. Nucleic Acids Res. 10:2893-2910.
2. Baker, C. J., and M. W. Edwards. 2005. Group B streptococcal infections, p. 1091-1156. In J. S. Remington, J. O. Klein, C. B. Wilson, and C. J. Baker (ed.), Infectious diseases of the fetus and newborn infant, 6th ed. Elsevier Saunders, Philadelphia, Pa.
3. Blancas, D., M. Santin, M. Olmo, F. Alcaide, J. Carratala, and F. Gudiol. 2004. Group B streptococcal disease in nonpregnant adults: incidence, clinical characteristics, and outcome. Eur. J. Clin. Microbiol. Infect. Dis. 23:168-173.
4. Chaffin, D. O., and C. E. Rubens. 1998. New vectors for blue/white screening and in vitro expression (IVET) in gram-positive bacteria. American Society for Microbiology Conference on Streptococcal Genetics, Vichy, France.
5. Chmouryguina, I., A. Suvorov, P. Ferrieri, and P. P. Cleary. 1996. Conservation of the C5a peptidase genes in group A and B streptococci. Infect. Immun. 64:2387-2390.
6. Cormack, B. P., R. H. Valdivia, and S. Falkow. 1996. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173:33-38.
7. Deora, R., and R. Misra. 1995. Purification and characterization of DNA dependent RNA polymerase from Staphylococcus aureus. Biochem. Biophys. Res. Commun. 208:610-616.
8. de Vos, W. M. 1986. Genetic improvement of starter streptococci by the cloning and expression of the gene coding for a nonbitter proteinase, p. 465-472. In E. Magnien (ed.), Biomolecular engineering in the European community: achievements of the research programme (1982-1986) final report. Martinus Nijhoff, Lancaster, England.
9. Ferretti, J. J., and R. Curtiss (ed.). 1987. Streptococcal genetics. American Society for Microbiology, Washington, D.C.
10. Framson, P., A. Nittayajarn, J. Merry, P. Youngman, and C. Rubens. 1997. New genetic techniques for group B streptococci: high-efficiency transformation, maintenance of temperature-sensitive pWV01 plasmids, and mutagenesis with Tn917. Appl. Environ. Microbiol. 63:3539-3547.
11. Gao, H., and A. I. Aronson. 2004. The delta subunit of RNA polymerase functions in sporulation. Curr. Microbiol. 48:401-404.
12. Glaser, P., C. Rusniok, C. Buchrieser, F. Chevalier, L. Frangeul, T. Msadek, M. Zouine, E. Couve, L. Lalioui, C. Poyart, P. Trieu-Cuot, and F. Kunst. 2002. Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol. Microbiol. 45:1499-1513.
13. Gotoff, S. P. 2002. Group B streptococcal infections. Pediatr. Rev. 23:381-386.
14. Gruber, T. M., and C. A. Gross. 2003. Multiple sigma subunits and the partitioning of bacterial transcription space. Annu. Rev. Microbiol. 57:441-466.
15. Haldenwang, W. G. 1995. The sigma factors of Bacillus subtilis. Microbiol. Rev. 59:1-30.
16. Helmann, J. D. 1995. Compilation and analysis of Bacillus subtilis sigma A-dependent promoter sequences: evidence for extended contact between RNA polymerase and upstream promoter DNA. Nucleic Acids Res. 23:2351-2360.
17. Helmann, J. D. 2003. Purification of Bacillus subtilis RNA polymerase and associated factors. Methods Enzymol. 370:10-24.
18. Jones, A. L., K. M. Knoll, and C. E. Rubens. 2000. Identification of Streptococcus agalactiae virulence genes in the neonatal rat sepsis model using signature-tagged mutagenesis. Mol. Microbiol. 37:1444-1455.
19. Jones, A. L., R. H. V. Needham, and C. E. Rubens. 2003. The delta subunit of RNA polymerase is required for virulence of Streptococcus agalactiae. Infect. Immun. 71:4011-4017.
20. Juang, Y. L., and J. D. Helmann. 1995. Pathway of promoter melting by Bacillus subtilis RNA polymerase at a stable RNA promoter: effects of temperature, delta protein, and sigma factor mutations. Biochemistry 34:8465-8473.
21. Lampe, M., C. Binnie, R. Schmidt, and R. Losick. 1988. Cloned gene encoding the delta subunit of Bacillus subtilis RNA polymerase. Gene 67:13-19.
22. Lancefield, R. C., M. McCarty, and W. N. Everly. 1975. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. J. Exp. Med. 142:165-179.
23. Lindahl, G., M. Stalhammar-Carlemalm, and T. Areschoug. 2005. Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin. Microbiol. Rev. 18:102-127.
24. Lopez de Saro, F. J., A. Y. Woody, and J. D. Helmann. 1995. Structural analysis of the Bacillus subtilis delta factor: a protein polyanion which displaces RNA from RNA polymerase. J. Mol. Biol. 252:189-202.
25. Lopez de Saro, F. J., N. Yoshikawa, and J. D. Helmann. 1999. Expression, abundance, and RNA polymerase binding properties of the delta factor of Bacillus subtilis. J. Biol. Chem. 274:15953-15958.
26. Losick, R., and J. Pero. 1976. Bacillus subtilis RNA polymerase and its modification in sporulating and phage-infected bacteria. Adv. Enzymol. Relat. Areas Mol. Biol. 44:165-185.
27. Luck, S., M. Torny, K. d'Agapeyeff, A. Pitt, P. Heath, A. Breathnach, and A. B. Russell. 2003. Estimated early-onset group B streptococcal neonatal disease. Lancet 361:1953-1954.
28. Luo, P., and D. A. Morrison. 2003. Transient association of an alternative sigma factor, ComX, with RNA polymerase during the period of competence for genetic transformation in Streptococcus pneumoniae. J. Bacteriol. 185:349-358.
29. Madoff, L. C., S. Hori, J. L. Michel, C. J. Baker, and D. L. Kasper. 1991. Phenotypic diversity in the alpha C protein of group B streptococci. Infect. Immun. 59:2638-2644.
30. Madoff, L. C., J. L. Michel, E. W. Gong, D. E. Kling, and D. L. Kasper. 1996. Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein. Proc. Natl. Acad. Sci. USA 93:4131-4136.
31. Manganelli, R., L. Fattorini, D. Tan, E. Iona, G. Orefici, G. Altavilla, P. Cusatelli, and I. Smith. 2004. The extra cytoplasmic function sigma factor σE is essential for Mycobacterium tuberculosis virulence in mice. Infect. Immun. 72:3038-3041.
32. Qi, Y., and F. M. Hulett. 1998. PhoP-P and RNA polymerase σA holoenzyme are sufficient for transcription of Pho regulon promoters in Bacillus subtilis: PhoP-P activator sites within the coding region stimulate transcription in vitro. Mol. Microbiol. 28:1187-1197.
33. Rabinowitz, S., M. Ferne, and S. T. Halfon. 1980. Group B streptococcal serotypes associated with clinical infection. Lab. Pract. 29:733-734.
34. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
35. Rubens, C. E., H. V. Raff, J. C. Jackson, E. Y. Chi, J. T. Bielitzki, and S. L. Hillier. 1991. Pathophysiology and histopathology of group B streptococcal sepsis in Macaca nemestrina primates induced after intraamniotic inoculation: evidence for bacterial cellular invasion. J. Infect. Dis. 164:320-330.
36. Sambrook, J., and D. W. Russel. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
37. Schrag, S, J., and A. Schuchat. 2004. Easing the burden: characterizing the disease burden of neonatal group B streptococcal disease to motivate prevention. Clin. Infect. Dis. 38:1209-1211.
38. Shaw, J. H., and D. B. Clewell. 1985. Complete nucleotide sequence of macrolide-lincosamide-streptogramin B-resistance transposon Tn917 in Streptococcus faecalis. J. Bacteriol. 164:782-796.
39. Spiegelman, G. B., W. R. Hiatt, and H. R. Whiteley. 1978. Role of the 21,000 molecular weight polypeptide of Bacillus subtilis RNA polymerase in RNA synthesis. J. Biol. Chem. 253:1756-1765.
40. Tettelin, H., V. Masignani, M. J. Cieslewicz, J. A. Eisen, S. Peterson, M. R. Wessels, I. T. Paulsen, K. E. Nelson, I. Margarit, T. D. Read, L. C. Madoff, A. M. Wolf, M. J. Beanan, L. M. Brinkac, S. C. Daugherty, R. T. DeBoy, A. S. Durkin, J. F. Kolonay, R. Madupu, M. R. Lewis, D. Radune, N. B. Fedorova, D. Scanlan, H. Khouri, S. Mulligan, H. A. Carty, R. T. Cline, S. E. Van Aken, J. Gill, M. Scarselli, M. Mora, E. T. Iacobini, C. Brettoni, G. Galli, M. Mariani, F. Vegni, D. Maione, D. Rinaudo, R. Rappuoli, J. L. Telford, D. L. Kasper, G. Grandi, and C. M. Fraser. 2002. Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc. Natl. Acad. Sci. USA 99:12391-12396.
41. Velaphi, S., J. D. Siegel, G. D. Wendel, Jr., N. Cushion, W. M. Eid, and P. J. Sanchez. 2003. Early-onset group B streptococcal infection after a combined maternal and neonatal group B streptococcal chemoprophylaxis strategy. Pediatrics 111:541-547.
42. Watson, S. P., M. Antonio, and S. J. Foster. 1998. Isolation and characterization of Staphylococcus aureus starvation-induced, stationary-phase mutants defective in survival or recovery. Microbiology 144:3159-3169.
43. Weisner, A. M., A. P. Johnson, T. L. Lamagni, E. Arnold, M. Warner, P. T. Heath, A. Efstratiou, G. Balfour, H. Tighe, L. A. O'Connell, M. Cafferkey, N. Q. Verlander, A. Nicoll, A. C. McCartney, C. Simon, H. Schroder, D. Weisner, M. Bruck, and U. Krieg. 2004. Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin. Infect. Dis. 38:1203-1208.
44. Wilkinson, H. W. 1977. Nontypable group B streptococci isolated from human sources. J. Clin. Microbiol. 6:183-184.